نتایج جستجو برای: food and drug administration fda

تعداد نتایج: 16951772  

2016

COMMERCIAL & MEDICAID COVERAGE RATIONALE ............................................................... 1 MEDICARE COVERAGE RATIONALE ............................................................................................... 2 DESCRIPTION OF SERVICES .............................................................................................................. 2 CLINICAL EVIDENCE ............

2014
Andrew W. Mulcahy Zachary Predmore Soeren Mattke

T he U.S. Food and Drug Administration (FDA) is expected to release final regulations outlining lower-cost approval pathway requirements for so-called biosimilar drugs. The introduction of biosimilars is expected to reduce prices, albeit

Journal: :Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2016
Yehuda Handelsman Robert R Henry Zachary T Bloomgarden Sam Dagogo-Jack Ralph A DeFronzo Daniel Einhorn Ele Ferrannini Vivian A Fonseca Alan J Garber George Grunberger Derek LeRoith Guillermo E Umpierrez Matthew R Weir

ABBREVIATIONS AACE = American Association of Clinical Endocrinologists ACE = American College of Endocrinology DKA = diabetic ketoacidosis EMA = European Medicines Agency FDA = U.S. Food and Drug Administration SGLT-2 = sodium glucosecotransporter 2 T1D = type 1 diabetes T2D = type 2 diabetes.

2016
Ferdinand Dhombres Vojtech Huser Laritza M. Rodriguez Olivier Bodenreider

Over eighty percent of pregnant women in the United States are prescribed at least one drug during pregnancy. The U.S. Food and Drug Administration (FDA) regulates the labeling of drug products and has established five risk categories for drug use during pregnancy. This classification was introduced in 1979. New FDA regulations (June 30, 2015) deeply revised the pregnancy and lactation labeling...

2015

In the article “Sodium Content in Packaged Foods by Census Division in the United States, 2009,” a recommendation by the Food and Drug Administration was incorrectly stated. A sentence in the article previously read, “The equivalized, sales-weighted proportion of products in each food category meeting Food and Drug Administration (FDA) sodium limits for foods using the ‘healthy’ label claim (ie...

2014
Diana W Shineman John Alam Margaret Anderson Sandra E Black Aaron J Carman Jeffrey L Cummings Penny A Dacks Joel T Dudley Donald E Frail Allan Green Rachel F Lane Debra Lappin Tanya Simuni Richard G Stefanacci Todd Sherer Howard M Fillit

Repurposing Food and Drug Administration (FDA)-approved drugs for a new indication may offer an accelerated pathway for new treatments to patients but is also fraught with significant commercial, regulatory, and reimbursement challenges. The Alzheimer's Drug Discovery Foundation (ADDF) and the Michael J. Fox Foundation for Parkinson's Research (MJFF) convened an advisory panel in October 2013 t...

2012
Changxing Shao Thomas C Dowling Sam Haidar Lawrence X Yu James E Polli Maureen A Kane

Abbreviations: UHPLC: Ultra-High-Performance Liquid Chromatography; HESI: Heated Electrospray Ionization; MS: Mass Spectrometry; MS/ MS: Tandem Mass Spectrometry; BCS: Biopharmaceutics Classification System; FDA: Food and Drug Administration; PK: Pharmacokinetic; IS: Internal Standard; m/z: mass-to-charge ratio; Cmax: Peak Plasma Concentration of Drug; Tmax: Time required to reach the peak plas...

Journal: :Lancet Neurology 2021

The anti-amyloid β monoclonal antibody aducanumab was approved on June 7, 2021, by the US Food & Drug Administration (FDA) for treatment of Alzheimer's disease.1 Approval provided under FDA's accelerated approval process drugs that treat serious conditions and fill an unmet need, based surrogate endpoint reduction amyloid plaques in brain.

Journal: :Processes 2022

As people around the world regard 2020 as year of COVID-19, medical community considers this to be second-best year, shared with 1996, respect number drug molecules approved by US Food and Drug Administration (FDA). Both years, had a record 53 new FDA. In 2020, chemical entities 13 biological medicines were approved, including 10 monoclonal antibodies, 2 antibody-drug conjugates, 3 peptides, ol...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید